Intracranial Hemorrhage Diagnosis & Treatment Market Research Report Information By Type (Intracerebral Hemorrhage, Subarachnoid Bleeding, Epidural Hematoma and Subdural Blood Hematoma), Diagnosis & Treatment (Diagnosis (CT, MRI, and Others) and Treatment (Medication and Surgery) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2032

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 17

2.2 RESEARCH OBJECTIVE 17

2.3 MARKET STRUCTURE 17

2.4 ASSUMPTIONS & LIMITATIONS 18

3 RESEARCH METHODOLOGY

3.1 DATA MINING 19

3.2 SECONDARY RESEARCH 20

3.3 PRIMARY RESEARCH 21

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.5 FORECASTING TECHNIQUES 23

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24

3.6.1 BOTTOM-UP APPROACH 25

3.6.2 TOP-DOWN APPROACH 25

3.7 DATA TRIANGULATION 26

3.8 VALIDATION 26

4 MARKET DYNAMICS

4.1 OVERVIEW 27

4.2 DRIVERS 29

4.2.1 LARGE NUMBER OF PATIENTS SUFFERING FROM BRAIN CANCER, ANEURYSM, AND RELATED CONDITIONS 29

4.2.2 GROWING NUMBER OF INCIDENCES OF TRAUMA AND ACCIDENTS LEADING TO TRAUMATIC BRAIN INJURY (TBI) 29

4.2.3 CLINICAL TRIALS TO IMPROVE AVAILABLE TREATMENTS 30

4.2.4 INCREASING HEALTHCARE EXPENDITURE 30

4.3 RESTRAINTS 31

4.3.1 INCREASING COUNTERFEIT DRUGS & SIDE EFFECTS OF THE TREATMENT 31

4.3.2 LACK OF SKILLED WORKFORCE 32

4.4 OPPORTUNITIES 33

4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING REGIONS 33

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 34

5.1.1 R&D 35

5.1.2 MANUFACTURING 35

5.1.3 DISTRIBUTION AND SALES 35

5.1.4 POST-SALES MONITORING 35

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 37

5.2.4 THREAT OF SUBSTITUTES 37

5.2.5 INTENSITY OF RIVALRY 37

5.3 COVID-19 IMPACT ANALYSIS 38

5.3.1 IMPACT ON GROWTH RATE 38

6 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE

6.1 OVERVIEW 39

6.2 INTRACEREBRAM HEMORRHAGE 40

6.3 SUBARACHNOID HEMORRHAGE 40

6.4 EPIDURAL HEMATOMA 41

6.5 SUBDURAL HEMATOMA 41

7 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS & TREATMENT

7.1 OVERVIEW 42

7.2 DIAGNOSIS 43

7.3 TREATMENT 44

8 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION

8.1 OVERVIEW 46

8.2 AMERICAS 47

8.2.1 NORTH AMERICA 50

8.2.1.1 US 53

8.2.1.2 CANADA 56

8.2.2 LATIN AMERICA 58

8.3 EUROPE 60

8.3.1 WESTERN EUROPE 63

8.3.1.1 GERMANY 66

8.3.1.2 FRANCE 68

8.3.1.3 UK 70

8.3.1.4 ITALY 72

8.3.1.5 SPAIN 74

8.3.1.6 REST OF WESTERN EUROPE 76

8.3.2 EASTERN EUROPE 78

8.4 ASIA-PACIFIC 80

8.4.1 CHINA 83

8.4.2 JAPAN 85

8.4.3 INDIA 87

8.4.4 AUSTRALIA 89

8.4.5 SOUTH KOREA 91

8.4.6 REST OF ASIA-PACIFIC 93

8.5 MIDDLE EAST & AFRICA 96

8.5.1 MIDDLE EAST 99

8.5.2 AFRICA 101

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 103

9.2 COMPETITIVE ANALYSIS 103

9.3 COMPETITIVE BENCHMARKING 104

9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 105

9.5 MAJOR GROWTH STRATEGY IN THE GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 105

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 106

9.6.1 PRODUCT APPROVALS 106

9.6.2 ACQUISITIONS 106

9.6.3 AGREEMENTS/COLLABORATIONS 106

10 COMPANY PROFILES

10.1 CANON INC. 107

10.1.1 COMPANY OVERVIEW 107

10.1.2 FINANCIAL OVERVIEW 108

10.1.3 PRODUCTS/SERVICES OFFERED 109

10.1.4 KEY DEVELOPMENTS 109

10.1.5 SWOT ANALYSIS 110

10.1.6 KEY STRATEGIES 110

10.2 FUJIFILM CORPORATION 111

10.2.1 COMPANY OVERVIEW 111

10.2.2 FINANCIAL OVERVIEW 112

10.2.3 PRODUCTS/SERVICES OFFERED 112

10.2.4 KEY DEVELOPMENTS 112

10.2.5 SWOT ANALYSIS 113

10.2.6 KEY STRATEGIES 113

10.3 GE HEALTHCARE 114

10.3.1 COMPANY OVERVIEW 114

10.3.2 FINANCIAL OVERVIEW 115

10.3.3 PRODUCTS/SERVICES OFFERED 116

10.3.4 KEY DEVELOPMENTS 116

10.3.5 SWOT ANALYSIS 117

10.3.6 KEY STRATEGIES 117

10.4 HITACHI, LTD 118

10.4.1 COMPANY OVERVIEW 118

10.4.2 FINANCIAL OVERVIEW 118

10.4.3 PRODUCTS/SERVICES OFFERED 119

10.4.4 KEY DEVELOPMENTS 119

10.4.5 SWOT ANALYSIS 120

10.4.6 KEY STRATEGIES 120

10.5 INFRASCAN, INC. 121

10.5.1 COMPANY OVERVIEW 121

10.5.2 FINANCIAL OVERVIEW 121

10.5.3 PRODUCTS/SERVICES OFFERED 121

10.5.4 KEY DEVELOPMENTS 121

10.5.5 SWOT ANALYSIS 122

10.5.6 KEY STRATEGIES 122

10.6 JOHNSON & JOHNSON 123

10.6.1 COMPANY OVERVIEW 123

10.6.2 FINANCIAL OVERVIEW 123

10.6.3 PRODUCTS/SERVICES OFFERED 124

10.6.4 KEY DEVELOPMENTS 124

10.6.5 SWOT ANALYSIS 125

10.6.6 KEY STRATEGIES 125

10.7 KONINKLIJKE PHILIPS NV 126

10.7.1 COMPANY OVERVIEW 126

10.7.2 FINANCIAL OVERVIEW 127

10.7.3 PRODUCTS/SERVICES OFFERED 128

10.7.4 KEY DEVELOPMENTS 128

10.7.5 SWOT ANALYSIS 129

10.7.6 KEY STRATEGIES 129

10.8 MEDTRONIC PLC 130

10.8.1 COMPANY OVERVIEW 130

10.8.2 FINANCIAL OVERVIEW 130

10.8.3 PRODUCTS/SERVICES OFFERED 131

10.8.4 KEY DEVELOPMENTS 131

10.8.5 SWOT ANALYSIS 132

10.8.6 KEY STRATEGIES 132

10.9 SIEMENS 133

10.9.1 COMPANY OVERVIEW 133

10.9.2 FINANCIAL OVERVIEW 134

10.9.3 PRODUCTS/SERVICES OFFERED 135

10.9.4 KEY DEVELOPMENTS 135

10.9.5 SWOT ANALYSIS 136

10.9.6 KEY STRATEGIES 136

10.10 STRYKER 137

10.10.1 COMPANY OVERVIEW 137

10.10.2 FINANCIAL OVERVIEW 137

10.10.3 PRODUCTS/SERVICES OFFERED 138

10.10.4 KEY DEVELOPMENTS 138

10.10.5 SWOT ANALYSIS 139

10.10.6 KEY STRATEGIES 139

11 APPENDIX

11.1 REFERENCES 140

11.2 RELATED REPORTS 140

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 18

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

TABLE 3 AVAILABILITY OF NEUROSURGEONS IN DEVELOPING ASIAN COUNTRIES, 2023 32

TABLE 4 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 40

TABLE 5 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET FOR INTRACEREBRAM HEMORRHAGE, BY REGION, 2023-2032 (USD MILLION) 40

TABLE 6 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET FOR SUBARACHNOID HEMORRHAGE, BY REGION, 2023-2032 (USD MILLION) 40

TABLE 7 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET FOR EPIDURAL HEMATOMA, BY REGION, 2023-2032 (USD MILLION) 41

TABLE 8 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET FOR SUBDURAL HEMATOMA, BY REGION, 2023-2032 (USD MILLION) 41

TABLE 9 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 42

TABLE 10 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY REGION, 2023-2032 (USD MILLION) 43

TABLE 11 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 43

TABLE 12 GLOBAL INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 44

TABLE 13 GLOBAL INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 45

TABLE 14 GLOBAL INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 45

TABLE 15 GLOBAL INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 45

TABLE 16 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 46

TABLE 17 AMERICAS: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 48

TABLE 18 AMERICAS: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 48

TABLE 19 AMERICAS: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 49

TABLE 20 AMERICAS: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 21 AMERICAS: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 22 AMERICAS: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 23 AMERICAS: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 50

TABLE 24 NORTH AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 51

TABLE 25 NORTH AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 51

TABLE 26 NORTH AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 51

TABLE 27 NORTH AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 28 NORTH AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 29 NORTH AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 30 NORTH AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 53

TABLE 31 US: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 53

TABLE 32 US: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 54

TABLE 33 US: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 34 US: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 35 US: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 55

TABLE 36 US: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 55

TABLE 37 CANADA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 38 CANADA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 56

TABLE 39 CANADA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 40 CANADA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 57

TABLE 41 CANADA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 57

TABLE 42 CANADA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 57

TABLE 43 LATIN AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 44 LATIN AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 58

TABLE 45 LATIN AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 46 LATIN AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 59

TABLE 47 LATIN AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 59

TABLE 48 LATIN AMERICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 59

TABLE 49 EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 60

TABLE 50 EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 61

TABLE 51 EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 61

TABLE 52 EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 61

TABLE 53 EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 62

TABLE 54 EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 62

TABLE 55 EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 62

TABLE 56 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 63

TABLE 57 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 58 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 64

TABLE 59 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 60 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 65

TABLE 61 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 65

TABLE 62 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 65

TABLE 63 GERMANY: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 64 GERMANY: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 66

TABLE 65 GERMANY: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 66 GERMANY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 67 GERMANY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 68 GERMANY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 69 FRANCE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 68

TABLE 70 FRANCE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 68

TABLE 71 FRANCE: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 68

TABLE 72 FRANCE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 69

TABLE 73 FRANCE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 69

TABLE 74 FRANCE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 69

TABLE 75 UK: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 76 UK: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 70

TABLE 77 UK: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 78 UK: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 71

TABLE 79 UK: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 71

TABLE 80 UK: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 71

TABLE 81 ITALY: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 72

TABLE 82 ITALY: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 72

TABLE 83 ITALY: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 72

TABLE 84 ITALY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 73

TABLE 85 ITALY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 73

TABLE 86 ITALY: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 73

TABLE 87 SPAIN: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 88 SPAIN: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 74

TABLE 89 SPAIN: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 90 SPAIN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 75

TABLE 91 SPAIN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 75

TABLE 92 SPAIN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 75

TABLE 93 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 76

TABLE 94 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 76

TABLE 95 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 76

TABLE 96 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 77

TABLE 97 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 77

TABLE 98 REST OF WESTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 77

TABLE 99 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 100 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 78

TABLE 101 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 102 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 79

TABLE 103 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 79

TABLE 104 EASTERN EUROPE: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 79

TABLE 105 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 81

TABLE 106 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 81

TABLE 107 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 81

TABLE 108 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 109 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 110 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 111 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 83

TABLE 112 CHINA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 83

TABLE 113 CHINA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 83

TABLE 114 CHINA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 84

TABLE 115 CHINA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 84

TABLE 116 CHINA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 84

TABLE 117 CHINA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 85

TABLE 118 JAPAN: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 85

TABLE 119 JAPAN: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 85

TABLE 120 JAPAN: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 121 JAPAN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 122 JAPAN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 123 JAPAN: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 87

TABLE 124 INDIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 87

TABLE 125 INDIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 87

TABLE 126 INDIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 127 INDIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 128 INDIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 129 INDIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 130 AUSTRALIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 131 AUSTRALIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 89

TABLE 132 AUSTRALIA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 90

TABLE 133 AUSTRALIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 90

TABLE 134 AUSTRALIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 90

TABLE 135 AUSTRALIA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 91

TABLE 136 SOUTH KOREA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 91

TABLE 137 SOUTH KOREA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 91

TABLE 138 SOUTH KOREA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 139 SOUTH KOREA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 140 SOUTH KOREA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 141 SOUTH KOREA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 142 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 143 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 93

TABLE 144 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 94

TABLE 145 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 94

TABLE 146 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 94

TABLE 147 REST OF ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 95

TABLE 148 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 96

TABLE 149 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 97

TABLE 150 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 97

TABLE 151 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 97

TABLE 152 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 98

TABLE 153 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 98

TABLE 154 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 98

TABLE 155 MIDDLE EAST: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 156 MIDDLE EAST: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 99

TABLE 157 MIDDLE EAST: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 158 MIDDLE EAST: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 100

TABLE 159 MIDDLE EAST: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 100

TABLE 160 MIDDLE EAST: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 100

TABLE 161 AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 101

TABLE 162 AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS AND TREATMENT, 2023-2032 (USD MILLION) 101

TABLE 163 AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION) 101

TABLE 164 AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023-2032 (USD MILLION) 102

TABLE 165 AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION) 102

TABLE 166 AFRICA: INTRACRANIAL HEMORRHAGE TREATMENT MARKET FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 102

TABLE 167 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, COMPANY RANKING ANALYSIS, 2023 103

TABLE 168 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 105

TABLE 169 PRODUCT APPROVALS/LAUNCHES 106

TABLE 170 ACQUISITIONS 106

TABLE 171 COLLABORATIONS 106

TABLE 172 CANON INC.: PRODUCTS/SERVICES OFFERED 109

TABLE 173 CANON INC.: KEY DEVELOPMENTS 109

TABLE 174 FUJIFILM CORPORATION: PRODUCTS/SERVICES OFFERED 112

TABLE 175 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 116

TABLE 176 HITACHI, LTD: PRODUCTS/SERVICES OFFERED 119

TABLE 177 HITACHI, LTD: KEY DEVELOPMENTS 119

TABLE 178 INFRASCAN, INC.: PRODUCTS/SERVICES OFFERED 121

TABLE 179 JOHNSON & JOHNSON: PRODUCTS/SERVICES OFFERED 124

TABLE 180 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 128

TABLE 181 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 128

TABLE 182 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 131

TABLE 183 SIEMENS: PRODUCTS/SERVICES OFFERED 135

TABLE 184 SIEMENS: KEY DEVELOPMENTS 135

TABLE 185 STRYKER: PRODUCTS/SERVICES OFFERED 138

TABLE 186 STRYKER: KEY DEVELOPMENTS 138

13 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 16

FIGURE 2 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 17

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 24

FIGURE 4 MARKET DYNAMICS: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 28

FIGURE 5 DRIVER IMPACT ANALYSIS 31

FIGURE 6 RESTRAINT IMPACT ANALYSIS 33

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 34

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 36

FIGURE 9 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2023 AND 2032 (USD MILLION) 39

FIGURE 10 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS & TREATMENT, 2023 AND 2032 (USD MILLION) 42

FIGURE 11 GLOBAL INTRACRANIAL HEMORRHAGE TREATMENT MARKET, BY TYPE, 2023 AND 2032 (USD MILLION) 44

FIGURE 12 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 46

FIGURE 13 AMERICAS: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 48

FIGURE 14 NORTH AMERICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 50

FIGURE 15 EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 60

FIGURE 16 WESTERN EUROPE: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 63

FIGURE 17 ASIA-PACIFIC: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION) 80

FIGURE 18 MIDDLE EAST & AFRICA: INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION, 2023 AND 2032 (USD MILLION) 96

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 104

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 105

FIGURE 21 CANON INC.: FINANCIAL OVERVIEW SNAPSHOT 108

FIGURE 22 CANON INC.: SWOT ANALYSIS 110

FIGURE 23 FUJIFILM CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 112

FIGURE 24 FUJIFILM CORPORATION: SWOT ANALYSIS 113

FIGURE 25 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 26 GE HEALTHCARE: SWOT ANALYSIS 117

FIGURE 27 HITACHI, LTD: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 28 HITACHI, LTD: SWOT ANALYSIS 120

FIGURE 29 INFRASCAN, INC.: SWOT ANALYSIS 122

FIGURE 30 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 31 JOHNSON & JOHNSON: SWOT ANALYSIS 125

FIGURE 32 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 127

FIGURE 33 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 129

FIGURE 34 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 130

FIGURE 35 MEDTRONIC PLC: SWOT ANALYSIS 132

FIGURE 36 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 134

FIGURE 37 SIEMENS: SWOT ANALYSIS 136

FIGURE 38 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 137

FIGURE 39 STRYKER: SWOT ANALYSIS 139